Experimental First-in-Human Anti-Cancer Drug Trials Coming to Grand Rapids

Published July 29, 2010

Experimental first-in-human anti-cancer drug trials coming to Grand Rapids
The trials will offer new hope to patients who are running out of options.
Read more on The Grand Rapids Press

Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2010
Varian Medical Systems today is reporting net earnings from continuing operations of $ 0.74 per diluted share in the third quarter of fiscal year 2010, up 9 percent from $ 0.68 per diluted share in the year-ago quarter. Â Including discontinued operations, net earnings for the third quarter of fiscal 2010 were $ 0.69 per diluted share. Â Revenues for the quarter were $ 578 million, up 13 percent …
Read more on PR Newswire via Yahoo! Finance